| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |